Clinical Trial Update: Taste And Smell TEsting in End Stage Renal Disease

View source ↗

Summary

The clinical trial NCT03043144 evaluating taste and smell testing in end-stage renal disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Malnutrition
• Olfactory Disorders
• Taste Disorders

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Kidney Failure, Chronic, Olfaction Disorders | Status: WITHDRAWN